SCIENTURE HOLDINGS, INC. Interest Income, Other
SCIENTURE HOLDINGS, INC. (SCNX) reported Interest Income, Other of $147.15 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeOther · last filed 2026-08-13
- SCIENTURE HOLDINGS, INC. interest income, other for the quarter ending 2026-06-30 was $147.15K, a 133.02% increase year-over-year.
- SCIENTURE HOLDINGS, INC. interest income, other for the quarter ending 2026-03-31 was $133.34K, a 424.11% increase year-over-year.
- SCIENTURE HOLDINGS, INC. interest income, other for the quarter ending 2025-12-31 was $212.99K, a 10878.97% increase year-over-year.
- SCIENTURE HOLDINGS, INC. interest income, other for the quarter ending 2025-09-30 was $1.12K, a 96.20% decline year-over-year.
- SCIENTURE HOLDINGS, INC. interest income, other for fiscal 2025 was $302.70K, a 123.67% increase from fiscal 2024.
- SCIENTURE HOLDINGS, INC. interest income, other for fiscal 2024 was $135.34K, a 3123.84% increase from fiscal 2023.
- SCIENTURE HOLDINGS, INC. interest income, other for fiscal 2023 was $4.20K, a 80.00% decline from fiscal 2022.
- SCIENTURE HOLDINGS, INC. interest income, other for fiscal 2022 was $20.99K.
| Period end | Interest Income, Other 3 month | Interest Income, Other 6 month | Interest Income, Other 9 month | Interest Income, Other 12 month |
|---|---|---|---|---|
| 2026-06-30 | $147.15K 10-Q · filed 2026-08-13 | $280.49K 10-Q · filed 2026-08-13 | $493.48K derived: sum of 3 quarters · filed 2026-08-13 | $494.60K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $133.34K 10-Q · filed 2026-05-15 | $346.34K derived: sum of 2 quarters · filed 2026-05-15 | $347.46K derived: sum of 3 quarters · filed 2026-05-15 | $410.60K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $212.99K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $214.11K derived: sum of 2 quarters · filed 2026-03-30 | $277.26K derived: sum of 3 quarters · filed 2026-08-13 | $302.70K 10-K · filed 2026-03-30 |
| 2025-09-30 | $1.12K 10-Q · filed 2025-11-12 | $64.27K derived: sum of 2 quarters · filed 2026-08-13 | $89.71K 10-Q · filed 2025-11-12 | $91.65K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $63.15K 10-Q · filed 2026-08-13 | $88.59K 10-Q · filed 2026-08-13 | $90.53K derived: sum of 3 quarters · filed 2026-08-13 | $119.97K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $25.44K 10-Q · filed 2026-05-15 | $27.38K derived: sum of 2 quarters · filed 2026-05-15 | $56.83K derived: sum of 3 quarters · filed 2026-05-15 | $97.86K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $1.94K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $31.39K derived: sum of 2 quarters · filed 2026-03-30 | $72.42K derived: sum of 3 quarters · filed 2026-03-30 | $135.34K 10-K · filed 2026-03-30 |
| 2024-09-30 | $29.45K 10-Q · filed 2025-11-12 | $70.48K derived: sum of 2 quarters · filed 2025-11-12 | $133.40K 10-Q · filed 2025-11-12 | $133.40K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $41.03K 10-Q · filed 2025-08-12 | $103.95K 10-Q · filed 2025-08-12 | $103.95K derived: sum of 3 quarters · filed 2025-08-12 | $103.95K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $62.92K 10-Q · filed 2025-05-12 | $62.92K derived: sum of 2 quarters · filed 2025-05-12 | $62.92K derived: sum of 3 quarters · filed 2025-05-12 | $62.92K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $0.00 derived: sum of 2 quarters · filed 2025-03-26 | $0.00 derived: sum of 3 quarters · filed 2025-03-26 | $4.20K 10-K · filed 2025-03-26 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $0.00 derived: sum of 2 quarters · filed 2024-11-06 | $4.20K 10-Q · filed 2024-11-06 | $16.79K derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $4.20K 10-Q · filed 2024-08-09 | $16.79K derived: sum of 3 quarters · filed 2024-08-09 | $25.19K derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $4.20K 10-Q · filed 2024-06-26 | $16.79K derived: sum of 2 quarters · filed 2024-06-26 | $25.19K derived: sum of 3 quarters · filed 2024-06-26 | |
| 2022-12-31 | $12.59K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-22 | $20.99K derived: sum of 2 quarters · filed 2024-04-22 | $20.99K 10-K · filed 2024-04-22 | |
| 2022-09-30 | $8.40K 10-Q · filed 2024-01-16 | $8.40K 10-Q · filed 2024-01-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |